Adma Biologics (ADMA) Gross Margin Growth (1y) (2012 - 2025)

Adma Biologics (ADMA) Gross Margin Growth (1y) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Adma Biologics 1.99 Bn 1.91 Bn 88.82 Mn 994.00

Historic Data

Download Data
DateValue
Dec 31, 2025 994.00
Sep 30, 2025 656.00
Jun 30, 2025 151.00
Mar 31, 2025 545.00
Dec 31, 2024 1,182.00
Sep 30, 2024 2,737.00
Jun 30, 2024 2,584.00
Mar 31, 2024 1,875.00
Dec 31, 2023 1,370.00
Sep 30, 2023 -109.00
Jun 30, 2023 1,740.00
Mar 31, 2023 1,643.00
Dec 31, 2022 2,198.00
Sep 30, 2022 2,164.00
Jun 30, 2022 1,598.00
Mar 31, 2022 2,331.00
Dec 31, 2021 4,332.00
Sep 30, 2021 -8,628.00
Jun 30, 2021 -9,435.00
Mar 31, 2021 5,427.00